Form 4 for MRNA Moderna
Accepted 2025-12-01 00:00:00 ET · period of report 2025-11-26 · accession 0001682852-25-000080 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-01 | 2025-11-26+ | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +1,102 | 28.9K | +4% | — |
| DM | 2025-12-01 | 2025-11-26+ | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $24.83 | -534 | 28.7K | -2% | -$13.3K |
| DM | 2025-12-01 | 2025-11-26+ | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | $0.00 | -1,102 | 1,644 | -40% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-28 | M | A | 329 | — | 28,898 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2025-11-26 | F | D | 374 | $24.75 | 28,569 | D | — | — | |
| 3 | Common | Common Stock | 2025-11-26 | M | A | 773 | — | 28,943 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 4 | Common | Common Stock | 2025-11-28 | F | D | 160 | $25.01 | 28,738 | D | — | — | |
| 5 | Derivative | Restricted Stock Units | 2025-11-26 | M | D | 773 | $0.00 | 6,963 | D | — · — to — | 773 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 6 | Derivative | Restricted Stock Units | 2025-11-28 | M | D | 329 | $0.00 | 1,644 | D | — · — to — | 329 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |